Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents
Citation
Patruno , I , Thompson , D , Dall'angelo , S , Windhorst , A D , Vugts , D J , Poot , A J , Mody , N & Zanda , M 2020 , ' Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents ' , ChemMedChem , vol. 15 , no. 16 , pp. 1579-1590 . https://doi.org/10.1002/cmdc.202000143
Rights
This is the peer reviewed version of the following article: Zanda, M., Patruno, I., Thompson, D., Dall'Angelo, S., Windhorst, A..D., Vugts, D..J., Poot, A..J. and Mody, N. (2020), Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndrome‐preventive agents. ChemMedChem 15(16) 1579-1590, which has been published in final form at https://doi.org/10.1002/cmdc.202000143. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.